This page shows the latest oseltamivir news and features for those working in and with pharma, biotech and healthcare.
compared with oseltamivir. ... Time to alleviation of influenza signs and symptoms were comparable between Xofluza and oseltamivir, Roche reported, at 138 hours and 150 hours, respectively.
Multiple treatments will be tested in the trial, including the anti-viral treatments Tamiflu (oseltamivir) and baloxavir, as well as steroids and anti-inflammatory drugs found to be effective against
miniSTONE-2 was a phase 3, multicentre, randomised, double-blind study that evaluated the safety, pharmacokinetics and effectiveness of a single-dose of Xofluza versus oseltamivir, in otherwise healthy children aged
It has already been shown to be effective against a wide range of flu viruses, including those resistant to Roche’s now off-patent and former blockbuster flu treatment, Tamiflu (oseltamivir).
oseltamivr. The approval was based on results from Roche’s phase 3 CAPSTONE-2 trial of Xofluza, compared to oseltamivir or placebo, in people aged 12 or over, who met the ... However, similar efficacy results were seen between Xofluza and oseltamivir
It applies mainly to hormone replacement therapies but also includes all adrenaline pens, hepatitis B vaccines and the influenza drug oseltamivir, sold by Roche as Tamiflu, amongst other drugs.
More from news
Approximately 0 fully matching, plus 38 partially matching documents found.
No results were found
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...